Natco Pharma Limited has informed the Exchange about Link of Recording
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma has submitted a regulatory filing under SEBI Listing Regulations informing exchanges about the availability of the earnings conference call transcript for Q4 FY25-26 held on May 29, 2026. The filing includes a link to the audio recording hosted on the company's website. No substantive details about the discussion or guidance provided during the call are included in this filing—it merely serves as a disclosure of where investors can access the transcript.
This filing is informational in nature and does not contain direct financial data or forward-looking statements. Investors seeking insights from the Q4 earnings call will need to review the linked transcript separately. The filing itself has no immediate bearing on the stock price.